
Integer Holdings (ITGR) Stock Forecast & Price Target
Integer Holdings (ITGR) Analyst Ratings
Bulls say
Integer Holdings Corp demonstrated substantial revenue growth in 3Q25, particularly with a 15% increase in the Cardio & Vascular segment, indicating strong performance within key product lines. The company’s gross margins are projected to remain stable, with an expected increase to 27.3% in 2025E, reinforcing operational efficiency and profitability. Furthermore, forecasted operating cash flow improvements and the resilience of the cardiovascular device market align with Integer's outlook for sustained above-market growth, positioning the company favorably against broader industry trends.
Bears say
Integer Holdings Corp has adjusted its revenue estimates for 4Q25 to $460 million, representing only a 2% year-over-year increase, reflecting a decline from previous projections of $477 million. The company's organic revenue guidance for FY26 has also been lowered, now expected to range from flat to +3%, indicating a deceleration in growth as demand for several of its products weakens. Additionally, the outlook for 2026 remains concerning due to anticipated declines in the Other Markets segment and potential downside risks if core sales and contributions from mergers and acquisitions do not meet expectations.
This aggregate rating is based on analysts' research of Integer Holdings and is not a guaranteed prediction by Public.com or investment advice.
Integer Holdings (ITGR) Analyst Forecast & Price Prediction
Start investing in Integer Holdings (ITGR)
Order type
Buy in
Order amount
Est. shares
0 shares